- Home
- GROW vs LSTA Comparison
GROW vs LSTA Comparison
Compare GROW & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROW
- LSTA
- Stock Information
- Founded
- GROW 1968
- LSTA 1980
- Country
- GROW United States
- LSTA United States
- Employees
- GROW N/A
- LSTA N/A
- Industry
- GROW Investment Managers
- LSTA Misc Health and Biotechnology Services
- Sector
- GROW Finance
- LSTA Health Care
- Exchange
- GROW Nasdaq
- LSTA Nasdaq
- Market Cap
- GROW 32.2M
- LSTA 22.3M
- IPO Year
- GROW N/A
- LSTA N/A
- Fundamental
- Price
- GROW $2.56
- LSTA $2.39
- Analyst Decision
- GROW
- LSTA Strong Buy
- Analyst Count
- GROW 0
- LSTA 2
- Target Price
- GROW N/A
- LSTA $23.50
- AVG Volume (30 Days)
- GROW 26.7K
- LSTA 21.2K
- Earning Date
- GROW 09-08-2025
- LSTA 11-11-2025
- Dividend Yield
- GROW 3.54%
- LSTA N/A
- EPS Growth
- GROW N/A
- LSTA N/A
- EPS
- GROW N/A
- LSTA N/A
- Revenue
- GROW $8,452,000.00
- LSTA $1,070,000.00
- Revenue This Year
- GROW N/A
- LSTA N/A
- Revenue Next Year
- GROW N/A
- LSTA N/A
- P/E Ratio
- GROW N/A
- LSTA N/A
- Revenue Growth
- GROW N/A
- LSTA N/A
- 52 Week Low
- GROW $2.02
- LSTA $1.87
- 52 Week High
- GROW $2.68
- LSTA $4.20
- Technical
- Relative Strength Index (RSI)
- GROW 62.39
- LSTA 51.61
- Support Level
- GROW $2.39
- LSTA $2.10
- Resistance Level
- GROW $2.57
- LSTA $2.43
- Average True Range (ATR)
- GROW 0.06
- LSTA 0.17
- MACD
- GROW 0.01
- LSTA 0.02
- Stochastic Oscillator
- GROW 85.00
- LSTA 82.05
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.